RMS was honored to participate in ESCRS Copenhagen 2025, one of the most prestigious international congresses in ophthalmology, where leading surgeons, researchers, and industry pioneers gathered to shape the future of cataract and refractive surgery. Our presence at ESCRS reflects RMS's commitment to bringing the latest innovations in ophthalmic care to healthcare professionals across the region. Throughout the congress, our team engaged with global experts, explored the newest scientific advances, and strengthened collaborations with our international partners to ensure that our portfolio continues to meet the highest standards of clinical excellence. As a trusted provider of advanced ophthalmic solutions, RMS showcased its comprehensive portfolio, including Cristalens® premium intraocular lenses, designed to provide outstanding visual outcomes for cataract patients, and ESW Vision technologies, featuring E-Eye® and Tearcheck® solutions for the diagnosis and management of Dry Eye Disease. Together, these technologies demonstrate our commitment to supporting ophthalmologists with innovative solutions that enhance both surgical outcomes and patient quality of life. ESCRS 2025 was an invaluable opportunity to exchange knowledge, discover emerging technologies, and reinforce our mission of delivering evidence-based, high-quality ophthalmic products that address the evolving needs of modern eye care. We thank all our partners, customers, and colleagues who met with our team during the congress. RMS remains dedicated to investing in innovation, building strong international partnerships, and bringing world-class ophthalmic technologies closer to clinicians—helping improve vision and transform patients' lives throughout the region.